Skip to main content

Table 3 Estimation of incremental costs as per life saved, per life year saved and per DALY averted in the PRIME

From: Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study

Estimation of incremental costs Vaccine price Scenario 5 Scenario 6 Scenario 7 Scenario 8 Scenario 9 Scenario 10 Scenario 11 (average cost)
Incremental cost per discounted life saved HPV vaccine with negotiated price from GAVI (13.65 US$ for 3 doses) 24,490 5,773 20,354 22,061 401 13,711 14,331
Cervarix vaccine with 106.8 US$ for 3 doses 122,510 103,793 118,374 120,081 97,619 111,731 112,351
Gardasil vaccine with 167.4 US$ for 3 doses 186,279 167,561 182,142 183,849 161,388 175,499 176,120
Incremental cost per discounted life year saved HPV vaccine with negotiated price from GAVI (13.65 US$ for 3 doses) 1,196 282 994 1,077 20 670 700
Cervarix vaccine with 106.8 US$ for 3 doses 5,983 5,069 5,781 5,865 4,768 5,457 5,487
Gardasil vaccine with 167.4 US$ for 3 doses 9,098 8,184 8,896 8,979 7,882 8,571 8,602
Incremental cost per discounted DALY averted HPV vaccine with negotiated price from GAVI (13.65 US$ for 3 doses) 1,103 260 917 994 18 618 645
Cervarix vaccine with 106.8 US$ for 3 doses 5,518 4,675 5,331 5,408 4,397 5,032 5,060
Gardasil vaccine with 167.4 US$ for 3 doses 8,390 7,547 8,203 8,280 7,269 7,904 7,932
  1. Unit cost: US$
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us